TaraChang United StatesStanford University

Tara I. Chang, MD, MS, is Professor of Medicine and Chief of the Division of Nephrology at Stanford University School of Medicine in Palo Alto, CA. In addition to seeing patients with all types of kidney disease and difficult-to-treat hypertension, Dr. Chang maintains an clinical research program that focuses on improving cardiovascular outcomes among patients with chronic kidney disease. She is a Deputy Editor for the American Journal of Kidney Diseases, and served as a member of the KDIGO Executive Committee and Blood Pressure in CKD Guidelines committee.

Institution

Day 2 - Monday April 15, 2024

Time	Session

09:00 10:30	Hypertension - the Cutting Edge: Advances in Science and Management IK03 TaraChang Chairperson United StatesStanford University Veronica Ferraris Chairperson veronica.ferraris@hospitalitaliano.org.arServicio de Nefrología Pediátrica. Hospital Italiano de Buenos Aires. (Argentina) Behind the Numbers: Exploring the Molecular Mechanisms of Hypertension GerardoGamba Speaker gamba@biomedicas.unam.mxMexicoUniversidad Nacional Autónoma de México Hypertension - the Cutting Edge: Is It Time for Sex-specific Management of Hypertension? TaliElfassy Speaker t.elfassy@med.miami.eduUnited States State-of-the-Art Treatment of Hypertension in Pediatrics With CKD RahulChanchlani Speaker chanchlr@mcmaster.caCanadaMcMaster Children's Hospital, Hamilton, Canada State-of-the-Art Treatment of Hypertension in Adults With CKD SusanneNicholas Speaker sunicholas@mednet.ucla.eduUnited StatesDavid Geffen School of Medicine at UCLA Q and A Hall D

Time

Session

09:00

10:30

Hypertension - the Cutting Edge: Advances in Science and Management

IK03

TaraChang Chairperson United StatesStanford University

Veronica Ferraris Chairperson veronica.ferraris@hospitalitaliano.org.arServicio de Nefrología Pediátrica. Hospital Italiano de Buenos Aires. (Argentina)

Behind the Numbers: Exploring the Molecular Mechanisms of Hypertension

GerardoGamba Speaker gamba@biomedicas.unam.mxMexicoUniversidad Nacional Autónoma de México
Hypertension - the Cutting Edge: Is It Time for Sex-specific Management of Hypertension?

TaliElfassy Speaker t.elfassy@med.miami.eduUnited States
State-of-the-Art Treatment of Hypertension in Pediatrics With CKD

RahulChanchlani Speaker chanchlr@mcmaster.caCanadaMcMaster Children's Hospital, Hamilton, Canada
State-of-the-Art Treatment of Hypertension in Adults With CKD

SusanneNicholas Speaker sunicholas@mednet.ucla.eduUnited StatesDavid Geffen School of Medicine at UCLA
Q and A

Hall D

Day 3 - Tuesday April 16, 2024

Time	Session

12:30 13:30	Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? IK05 MarceloOrías Chairperson marcelo.orias@gmail.comArgentina MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS JordanaCohen Speaker jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS TaraChang Speaker United StatesStanford University Hall A

Time

Session

12:30

13:30

Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120?

IK05

MarceloOrías Chairperson marcelo.orias@gmail.comArgentina

MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center

Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS

JordanaCohen Speaker jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania
Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS

TaraChang Speaker United StatesStanford University

Hall A